Benchmark Research has announced a new site located in Shreveport, Louisiana will bring the company to 9 sites total across the states of Texas, California, and Louisiana. This clinic will be Benchmark’s first to focus on In-patient and out-patient psychiatric studies as well as groundbreaking studies with Cannabis and Psychedelics such as LSD, Psilocybin, Ketamine, MDMA, and others.
Benchmark Shreveport (SHV) will be spearheaded by Brian Wooten, the prior owner of the clinic. Brian is a CCRC with a master’s degree in clinical psychology. In the past 27 years throughout his career, he has held various positions in psychiatric medicine management including 25 years in various roles in psychiatric clinical research from CRC to site owner.
Read more about the new clinic here.